Aquarius Surgical Technologies Inc.
AQQRF
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.60K | 12.70K | 11.10K | 9.40K | 27.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.60K | 12.70K | 11.10K | 9.40K | 27.50K |
| Cost of Revenue | 6.60K | 5.80K | 4.30K | 4.90K | 13.00K |
| Gross Profit | 7.00K | 6.90K | 6.80K | 4.50K | 14.50K |
| SG&A Expenses | 72.70K | 64.20K | 59.80K | 131.60K | 108.10K |
| Depreciation & Amortization | 4.90K | 4.80K | 4.70K | 5.20K | 5.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.20K | 74.80K | 68.80K | 141.70K | 126.50K |
| Operating Income | -70.60K | -62.10K | -57.70K | -132.30K | -99.00K |
| Income Before Tax | -582.50K | 514.60K | -334.80K | -173.80K | -161.60K |
| Income Tax Expenses | 4.50K | -- | 1.10K | -- | -- |
| Earnings from Continuing Operations | -587.00K | 514.60K | -335.90K | -173.80K | -161.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -587.00K | 514.60K | -335.90K | -173.80K | -161.60K |
| EBIT | -70.60K | -62.10K | -57.70K | -132.30K | -99.00K |
| EBITDA | -65.70K | -61.70K | -57.30K | -127.10K | -93.60K |
| EPS Basic | -0.02 | 0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | 0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M |
| Average Diluted Shares Outstanding | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |